[ad_1]
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
- Acumen Pharmaceuticals, Inc. ABOS shares rose 103.8% to close at $9.58 after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
- Prothena Corporation plc PRTA shares jumped 87.5% to close at $58.00 on Wednesday after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate. Prothena is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative diseases, like Alzheimer’s.
- Biogen Inc. BIIB shares rose 39.9% to close at $276.61. Biogen and Eisai Co. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate.
- Ginkgo Bioworks Holdings, Inc. DNA gained 20.1% to close at $3.47.
- Denali Therapeutics Inc. DNLI gained 17.7% to close at $32.12.
- Workiva Inc. WK jumped 17.6% to close at $76.15. Workiva is said to draw Thoma Bravo, TPG interest, Bloomberg reported.
- Coeur Mining, Inc. CDE jumped 15.2% to close at $3.26.
- Peabody Energy Corporation BTU gained 11.6% to close at $24.85.
- Rumble Inc. RUM gained 11.4% to close at $12.99 amid the start of Russell Brand’s show on the platform. It was also rumored Elon Musk may appear on the show next week.
- Alpha Metallurgical Resources, Inc. AMR jumped 11.3% to close at $138.60.
- EQRx, Inc. EQRX gained 11.1% to settle at $5.20.
- Guardant Health, Inc. GH jumped 10.7% to close at $54.89.
- Chegg, Inc. CHGG rose 10.6% to settle at $22.68.
- HashiCorp, Inc. HCP gained 10.5% to settle at $32.83.
- Eve Holding, Inc. EVEX jumped 10% to close at $11.02.
- Netflix, Inc. NFLX gained 9.3% to close at $245.20 after Atlantic Equities upgraded the stock from Neutral to Overweight and raised its price target from $211 to $283.
- Illumina, Inc. ILMN jumped 7.7% to close at $201.29 after Evercore ISI Group upgraded the stock from In-Line to Outperform and announced a $250 price target.
- Lilly and Company LLY rose 7.5% to close at $334.38. Shares of companies with potential Alzheimer’s treatments traded higher in sympathy with Biogen.
- Hess Corporation HES gained 7.1% to close at $108.30.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.